1-1 of 1
Peter Kier
Close
Save search
Sort by
Journal Articles

Combination Therapy with Lenalidomide, Bortezomib, Liposomal Doxorubicin and Dexamethasone (LBlipDD) May Overcome Resistance to Prior Treatment with Doxorubicin, Lenalidomide, and Bortezomib in High-Risk Multiple Myeloma (MM).

Free
Reinhard Ruckser, Georg Tatzreiter, Elvira Kitzweger, Karin Strecker, Stefan Hraby, Veronika Buxhofer, Margarete Stampfl, Peter Kier, Karl H. Habertheuer, Milos Hejtman, Wolfgang Hinterberger
Journal: Blood
Blood (2007) 110 (11): 4838.
https://doi.org/10.1182/blood.V110.11.4838.4838
Published: 2007